Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Completed 7Terminated 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 1Endocrine 1Breast 1

Conditions

Pain 1Multiple Myeloma 1Dwarfism, Pituitary 1Disease Progression 1Breast Neoplasms 1Bone Diseases, Metabolic 1

Interventions

Cyclophosphamide 222pembrolizumab 201Carboplatin 173Cisplatin 168Gemcitabine 167Paclitaxel 155Docetaxel 140Bevacizumab 138Rituximab 137Radiotherapy 137Nivolumab 126Dexamethasone 126Capecitabine 103fludarabine 102Pemetrexed 92fludarabine phosphate 91Fluorouracil 91Doxorubicin 85Oxaliplatin 79Etoposide 77Cytarabine 77Bortezomib 76Erlotinib Hydrochloride 74Leucovorin 72Filgrastim 68Lenalidomide 67Calcium Dobesilate 66Irinotecan 65atezolizumab 63Radiation 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Has results × Calcium × Clear all
NCT00998738 2016-02-04

Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer

Mayo Clinic

Phase 3 Terminated
1 enrolled 1 chart
Breast

Breast Neoplasms, Pain

NCT00145704 2013-04-08

Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density

State University of New York - Upstate Medical University

Phase NA Terminated
6 enrolled 3 charts
Endocrine

Bone Diseases, Metabolic, Dwarfism, Pituitary

NCT00171925 2012-04-11

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I

Novartis

Phase 3 Terminated
143 enrolled 10 charts
Plasma cell

Multiple Myeloma, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡